BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag088
Roberto M Montorsi, Alessio Marchetti, Tessa E Hendriks, Freek Daams, Olivier R Busch, Bas Groot Koerkamp, Matteo De Pastena, Hjalmar C van Santvoort, Bert A Bonsing, Salvatore Paiella, Giuseppe Malleo, Marc G Besselink, Roberto Salvia
{"title":"Preventing pancreatic fistula following pancreatectomy: meta-analysis of randomized clinical trials.","authors":"Roberto M Montorsi, Alessio Marchetti, Tessa E Hendriks, Freek Daams, Olivier R Busch, Bas Groot Koerkamp, Matteo De Pastena, Hjalmar C van Santvoort, Bert A Bonsing, Salvatore Paiella, Giuseppe Malleo, Marc G Besselink, Roberto Salvia","doi":"10.1093/bjsopen/zrag088","DOIUrl":"10.1093/bjsopen/zrag088","url":null,"abstract":"<p><strong>Background: </strong>The majority of postoperative morbidity and mortality after partial pancreatectomy is attributable to postoperative pancreatic fistula. Several interventions to prevent postoperative pancreatic fistula have been assessed in randomized clinical trials but consensus on their efficacy is lacking. This is the first systematic review and meta-analysis of randomized trials focusing on strategies to prevent postoperative pancreatic fistula after all types of partial pancreatectomy.</p><p><strong>Methods: </strong>Eligible randomized clinical trials assessing postoperative pancreatic fistula following partial pancreatectomy were included from the Evidence Map of Pancreatic Surgery database (2005-2025). As primary endpoint, both the 2005 and 2016 International Study Group for Pancreatic Surgery definitions of grade B/C postoperative pancreatic fistula were accepted. Interventions shown to reduce postoperative pancreatic fistula in at least one randomized trial were identified, and meta-analysis undertaken for those with at least three available trials, irrespective of their outcome.</p><p><strong>Results: </strong>Overall, 193 RCTs were included with 29 408 patients from 24 countries. The pooled rate of postoperative pancreatic fistula grade B/C was 15.1%: 14.2% after pancreatoduodenectomy and 19.1% after left pancreatectomy. Overall, 24 trials identified 18 interventions as effective in reducing the rate of postoperative pancreatic fistula: 11 intraoperative and 7 postoperative. Eight interventions were eligible for meta-analysis, involving 46 trials. Following meta-analysis, three interventions remained effective: drain omission in left pancreatectomy, perioperative use of somatostatin analogues, and administration of perioperative corticosteroids. The certainty of evidence was high for drain omission, moderate for somatostatin analogues, and low for corticosteroids. Eleven trials focused specifically on high-risk patients and four on ongoing postoperative pancreatic fistula. No trial combined interventions.</p><p><strong>Conclusion: </strong>Omission of drains in left pancreatectomy, perioperative use of somatostatin analogues, and administration of perioperative corticosteroids are effective strategies to prevent postoperative pancreatic fistula after partial pancreatectomy. However, current evidence remains immature and further RCTs evaluating these interventions are warranted, as they are likely to change the conclusions of subsequent meta-analyses. Such trials could potentially focus on high-risk patient cohorts and/or assess combinations of interventions.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag139
Florine I de Haes, Meis Uijttewaal, Nicolaas H Sperna Weiland, Martijn L M Broeren, Dorien A Salentijn
{"title":"Environmental benefits of reintroducing reusable drapes and gowns in the operating room.","authors":"Florine I de Haes, Meis Uijttewaal, Nicolaas H Sperna Weiland, Martijn L M Broeren, Dorien A Salentijn","doi":"10.1093/bjsopen/zrag139","DOIUrl":"10.1093/bjsopen/zrag139","url":null,"abstract":"<p><strong>Background: </strong>The healthcare sector contributes significantly to environmental pollution, which adversely affects human health. Operating rooms are a major source of this impact, partially due to the routine use of disposable materials prepacked in surgical trays. The main objective of this study was to compare the environmental impacts of fully disposable surgical trays with those of hybrid surgical trays, which replace disposable drapes and gowns with reusable ones.</p><p><strong>Methods: </strong>This multicentre study included surgical trays from three types of surgeries: gynaecological laparoscopy surgery, extremity surgery, and caesarean section. This selection captures a broad range of surgical workflows and instrument requirements, enabling the development of an average tray composition and enhancing the generalizability of the findings across various surgical specialties. The hybrid trays, including reusable drapes and gowns, were developed and tested specifically for this study. A life cycle assessment was conducted according to ISO 14040/44 standards to compare the environmental impacts of the hybrid and disposable trays across 18 impact categories.</p><p><strong>Results: </strong>Hybrid trays demonstrated lower environmental impacts than disposable trays across almost all impact categories. For climate change, hybrid trays reduced impact by 40-51%. In disposable trays, drapes and gowns contributed to approximately 69% of the total climate change impact, whereas in hybrid trays this contribution decreased to 38%, primarily because the production and end-of-life impacts of reusable drapes and gowns are distributed over multiple uses.</p><p><strong>Conclusion: </strong>These results provide a robust evidence base to inform and support a broader European Union-wide transition to hybrid trays, incorporating reusable drapes and gowns, in operating rooms.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag175
Ebba Kihlstedt Pasquier, Ellen Andersson, Johanna Österberg, Per Sandström, Bergthor Björnsson
{"title":"Elective cholecystectomy benchmarks: nationwide registry study.","authors":"Ebba Kihlstedt Pasquier, Ellen Andersson, Johanna Österberg, Per Sandström, Bergthor Björnsson","doi":"10.1093/bjsopen/zrag175","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag175","url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic cholecystectomy is the treatment of choice for symptomatic gallstone disease. The aim of this study was to establish clinically relevant benchmarks for elective laparoscopic cholecystectomy (ELC) to guide quality initiatives and support improvements in patient outcomes.</p><p><strong>Method: </strong>The Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography provided data on patients treated with primary ELC for a benign indication between 2015 and 2023. Exclusion criteria were common bile duct stones or stents detected before surgery, suspicion of bile duct obstruction, abnormal or unperformed intraoperative cholangiogram, previous major upper abdominal surgery, concomitant surgical procedures, and robotic surgery. The Achievable Benchmark of Care methodology was used to develop intra- and postoperative benchmarks, with severe postoperative complications (Clavien-Dindo ≥ III) representing the primary outcome. During surgery, serious adverse events were defined as intestinal perforation, bile leakage, or bleeding requiring transfusion or conversion to open surgery. Postoperative outcomes were assessed up to 30 days after surgery. Logistic regression identified risk factors for severe postoperative complications.</p><p><strong>Results: </strong>Overall, 48 564 patients undergoing ELCs across 81 surgical facilities were included. Among these, 69% were women. Median age was 50 (range 18-95) years and 91.4% were classified as American Society of Anesthesiologists classification ≤ II. Ten benchmarks were developed, capturing either intraoperative events (3) or postoperative complications (7). During surgery, 0.5% of the total cohort experienced a serious adverse event (median 0.3%, interquartile range 0.2-0.7% between facilities)-benchmark was 0.2%. Severe postoperative complications occurred in 1.7% of patients (median 1.6%, interquartile range 1.0-2.2% between facilities)-benchmark was 1.0%. Postoperative mortality was low (7 deaths, < 0.1%). At multivariable analysis, American Society of Anesthesiologists classification ≥ III (odds ratio 1.35, 95% confidence interval 1.05 to 1.72; P = 0.018), previous abdominal surgery (odds ratio 2.15, 1.24 to 3.75; P = 0.007), and intraoperative assessment of an altered gallbladder morphology (odds ratio 1.24, 1.01 to 1.52; P = 0.044) were independently associated with severe postoperative complications.</p><p><strong>Conclusion: </strong>This study provides benchmarks for elective laparoscopic cholecystectomy. When compared with real-world performance, these benchmarks highlight potential areas for quality improvement.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag111
Nathan Bontekoning, Hannah Groenen, Stijn W de Jonge, Markus W Hollmann, Marja A Boermeester, Marcel G W Dijkgraaf, Niels Wolfhagen
{"title":"Costs and health burden of surgical site infections and anastomotic leakage in major abdominal surgery.","authors":"Nathan Bontekoning, Hannah Groenen, Stijn W de Jonge, Markus W Hollmann, Marja A Boermeester, Marcel G W Dijkgraaf, Niels Wolfhagen","doi":"10.1093/bjsopen/zrag111","DOIUrl":"10.1093/bjsopen/zrag111","url":null,"abstract":"<p><strong>Background: </strong>Surgical site infection (SSI) is a common postoperative complication. SSI, including anastomotic leakage (AL), is a burden for patients and leads to increased costs, although insights as to the true costs from prospective data are limited. This study aimed to provide an overview of the impact of SSI and AL specifically on total societal costs and the quality of life (QoL) of patients.</p><p><strong>Method: </strong>This is a secondary analysis from the EPO2CH trial conducted between 2016 and 2020, which randomized patients scheduled for elective abdominal surgery with incisions > 5 cm to either standard care or standard care plus a bundle aiming to reduce SSI. Prospectively collected clinical data from the EPO2CH trial were used to ascertain the occurrence of SSI (superficial/deep/organ space and AL). The costs and QoL of patients with versus without SSI within 90 days after surgery were evaluated. The primary outcomes were costs (€) and (loss of) health utility, measured as quality-adjusted life-years (QALYs). QoL data were collected using patient questionnaires (EQ-5D™-3L). Unit costs were based on national guidelines for health economic evaluations and locally available unit costs of care.</p><p><strong>Results: </strong>Overall, 1119 of 1777 patients were analysed. Costs in the SSI and non-SSI groups were €53 562 (bias-corrected and accelerated (BCa) 95% confidence interval (c.i.) 45 356 to 68 600]) and €23 969 (BCa 95% c.i. 22 961 to 25 075), respectively, with a mean difference of €29 592 (BCa 95% c.i. 21 206 to 45 674). The greatest mean difference was observed between patients with AL and patients without SSI (€56 401; BCa 95% c.i. 39 487 to 90 892). The maximum attainable mean QALY score over 3 months was 0.25. The mean(standard deviation) QALY score in SSI and non-SSI patients was 0.171(0.050) and 0.205(0.037), respectively, with a mean difference of -0.035 (BCa 95% c.i. -0.042 to -0.029). This corresponds to a loss of 12.78 days in perfect health over the 3-month period.</p><p><strong>Conclusion: </strong>Patients with SSI, regardless of its type, had substantially higher healthcare costs and lower QoL after major abdominal surgery than patients without SSI.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13621077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anterior tumour location as a risk factor for local recurrence after laparoscopic surgery for stage I ultra-low rectal cancers: exploratory analysis of the Ultimate trial.","authors":"Atsushi Kohyama, Shinobu Ohnuma, Yuichiro Tsukada, Michiaki Unno, Jun Watanabe, Yosuke Fukunaga, Yasumitsu Hirano, Kazuhiro Sakamoto, Hiroki Hamamoto, Masanori Yoshimitsu, Hisanaga Horie, Nobuhisa Matsuhashi, Yoshiaki Kuriu, Shuntaro Nagai, Madoka Hamada, Shinichi Yoshioka, Tamuro Hayama, Koki Otsuka, Yusuke Inoue, Kazuki Ueda, Yuji Toiyama, Satoshi Maruyama, Shigeki Yamaguchi, Keitaro Tanaka, Motoko Suzuki, Toshihiro Misumi, Takeshi Naitoh, Masahiko Watanabe, Masaaki Ito","doi":"10.1093/bjsopen/zrag128","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag128","url":null,"abstract":"<p><strong>Background: </strong>Anterior tumour location is an established risk factor for local recurrence (LR) in advanced rectal cancer, but its significance in stage I ultra-low rectal cancer remains unclear.</p><p><strong>Methods: </strong>This exploratory supplemental analysis used data from Ultimate trial, a multicentre prospective phase II study across 47 Japanese institutions (2014-2017). Patients with cT1-2 N0 M0 ultra-low rectal cancer (≤ 5 cm from the anal verge) underwent laparoscopic resection. Tumour location was categorized as anterior (10-2 o'clock) or non-anterior (2-10 o'clock). The primary endpoint was LR; secondary endpoints included recurrence-free survival, overall survival, and stoma-free survival.</p><p><strong>Results: </strong>Of 300 enrolled patients, 297 were analysed (median follow-up 37.2 months); 93 tumours (31.3%) were anterior. Baseline characteristics, operative outcomes, and pathological findings were similar between the two groups. The 3-year cumulative LR rate was 11.9% for anterior tumours and 3.0% for non-anterior tumours (hazard ratio (HR) 4.46; 95% confidence interval (c.i.) 1.67 to 11.89; P = 0.001). Multivariable analysis showed an independent association between anterior location and LR (HR 4.68; 95% c.i. 1.72 to 12.74); subgroup analysis revealed no difference in clinical (c) T1 patients, but a significantly higher LR rate for anterior tumours in cT2 patients (25.3% versus 4.7%; P < 0.001). Three-year recurrence-free survival (83.9% for anterior tumours versus 88.9% for non-anterior tumours; P = 0.222), overall survival (> 95%), and stoma-free survival were comparable between the two groups.</p><p><strong>Conclusion: </strong>Anterior tumour location in the ultra-low rectum was associated with an increased risk of LR, particularly in cT2 patients, highlighting the need for a more refined treatment strategy and vigilant monitoring.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13626249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag129
Tyler R Chesney, Camilla L Wong, Andrea C Tricco, Duminda N Wijeysundera, Marisa Louridas, Kesikan Jayaraj, Claire Sethuram, Amanda Mac, Shawn Khan, Victoria B Anthes, Madeline McDonald, Betty Yibrehu, Amanda Poxon, Anas Samman, Valerie Kim, Karim S Ladha, Teruko Kishibe, Samuel Dubé, Martine Puts, Shabbir M H Alibhai, Julian F Daza
{"title":"Frailty assessment tools for preoperative evaluation of older adults: scoping review.","authors":"Tyler R Chesney, Camilla L Wong, Andrea C Tricco, Duminda N Wijeysundera, Marisa Louridas, Kesikan Jayaraj, Claire Sethuram, Amanda Mac, Shawn Khan, Victoria B Anthes, Madeline McDonald, Betty Yibrehu, Amanda Poxon, Anas Samman, Valerie Kim, Karim S Ladha, Teruko Kishibe, Samuel Dubé, Martine Puts, Shabbir M H Alibhai, Julian F Daza","doi":"10.1093/bjsopen/zrag129","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag129","url":null,"abstract":"<p><strong>Background: </strong>Optimal frailty assessment in surgery remains unclear due to insufficient tool performance evaluations. This scoping review summarizes evidence on frailty tools in the preoperative setting, focusing on key performance metrics.</p><p><strong>Methods: </strong>Following JBI and PRISMA-ScR recommendations, the MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature databases were systematically searched (2005-May 2026), for studies evaluating performance metrics of frailty tools in adults aged ≥ 65 years undergoing major intracavitary surgery. Two reviewers conducted screening and data charting. Data were analysed on settings, surgical types, and six performance metrics across measurement properties, clinical impact, and pragmatic factors.</p><p><strong>Results: </strong>From 12 272 records, 160 unique studies on 35 frailty tools were included. Some tools were extensively investigated (up to 41 studies and 11 287 participants), whereas 40% of tools had been investigated in only one study. Predictive validity was commonly studied, whereas reliability, clinical impact, and pragmatic factors were less explored. The Clinical Frailty Scale was extensively studied, covering four of six performance metrics across diverse settings and surgical types. The Edmonton Frail Scale was the only tool investigated across all six metrics, although reliance on performance and cognitive testing may hinder implementation. The FRAIL scale, Geriatric 8, and Vulnerable Elders Survey-13 are simple questionnaires, with the FRAIL scale being the most extensively investigated (five of six metrics).</p><p><strong>Conclusion: </strong>Several frailty assessment tools show promise based on investigation extent and features. This review aids clinical teams in identifying tools that meet specific local needs. Further research should focus on clinical impact and pragmatic factors, as well as tool-specific meta-analyses of performance metrics to enhance tool selection and implementation.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag147
Renato Pitesa, Stephanie Moody, Andrew G Hill
{"title":"Patient-initiated follow-up in surgical specialties: meta-analysis and meta-regression.","authors":"Renato Pitesa, Stephanie Moody, Andrew G Hill","doi":"10.1093/bjsopen/zrag147","DOIUrl":"10.1093/bjsopen/zrag147","url":null,"abstract":"<p><strong>Background: </strong>Rising outpatient demand has accelerated adoption of patient-initiated follow-up in surgical practice. This review evaluated whether patient-initiated follow-up safely reduces clinic burden while maintaining patient outcomes across specialties.</p><p><strong>Methods: </strong>MEDLINE, Embase, and CENTRAL were searched (2014-2025) for studies of patient-initiated follow-up, defined as a model enabling clinically stable patients to self-initiate follow-up when new or concerning symptoms arise, rather than attending prearranged appointments. Primary outcomes included outpatient appointment volume and patient-reported quality of life. Where studies reported single-arm utilization data, a random-effects meta-analysis of proportions was undertaken. Exploratory meta-regression examined pathway-level factors associated with utilization. Randomized clinical trials (RCTs) were assessed using the revised Cochrane risk-of-bias 2 tool, observational cohort studies using the Newcastle-Ottawa Scale, and qualitative studies using the Critical Appraisal Skills Programme checklist.</p><p><strong>Results: </strong>Of 1776 manuscripts identified, 34 studies across 6 surgical specialties (breast, colorectal, otorhinolaryngology, orthopaedics, plastics, and urology) were included: 4 RCTs, 17 observational cohort studies, 11 qualitative studies, and 2 mixed-methods studies. Observational studies consistently reported reductions in routine outpatient attendance-including a reduction from 45·0% to 6·0% in first specialist appointments in patient-initiated follow-up in colorectal surgery (P < 0·001) and 52·5% of patients with high-risk cutaneous squamous cell carcinoma not recontacting the clinic-without evidence of increased adverse outcomes. RCTs demonstrated non-inferior patient-reported quality-of-life outcomes with patient-initiated versus standard follow-up, alongside reductions in physician contact, including a 50% reduction in planned consultations in breast cancer (1·9 versus 3·8 per patient; P < 0·001) and a reduction in specialist contacts from 42·0% to 23·0% in rectal cancer. In a meta-analysis (1806 participants), the pooled patient-initiated follow-up utilization proportion was 0·19 (95% confidence interval 0·09 to 0·36; I2 = 95%), indicating substantial context-dependent variation. In oncological settings-particularly breast, colorectal, melanoma, and head and neck cancer-structured surveillance and rapid-access systems were identified as critical safety adjuncts to implementation.</p><p><strong>Conclusion: </strong>Patient-initiated follow-up can reduce outpatient burden in selected surgical populations without compromising patient-reported outcomes; however, its effects are dependent on the clinical context and pathway design. Risk-stratified and hybrid models may be the most appropriate, particularly in oncology. Further high-quality trials and robust economic evaluations are required to define optimal implementation strat","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag151
Anders O J Bergenfelz, Mark Thier, Martin Almquist, Jonas P Ranstam, Erik D Nordenström
{"title":"Surgery versus observation in patients 65 years or older with primary hyperparathyroidism: randomized clinical trial.","authors":"Anders O J Bergenfelz, Mark Thier, Martin Almquist, Jonas P Ranstam, Erik D Nordenström","doi":"10.1093/bjsopen/zrag151","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag151","url":null,"abstract":"<p><strong>Background: </strong>A substantial portion of surgically treated patients with primary hyperparathyroidism (pHPT) are older than 65 years. The indication for parathyroidectomy in older patients with pHPT and mild hypercalcaemia is unclear. Specifically, it is not known whether parathyroid surgery improves bone mineral density (BMD) in this age group.</p><p><strong>Method: </strong>Patients 65 years or older with pHPT, ionized calcium not exceeding 1.50 mmol/l, and a BMD Z-score above -2.5 standard deviations who were referred to the Department of Surgery, Lund University Hospital, were included in the study. Follow-up was performed over 2 years. The random allocation sequence to surgery or observation was computer generated. There was no blinding. Primary outcome was BMD of the hip, with the primary endpoint being the change in total hip BMD from baseline to the end of follow-up. Secondary outcome was BMD of the lumbar spine. Continuous variables were analysed using Satterthwaite's t-test. Intention-to-treat analysis of change from baseline was performed using a mixed-model repeated-measures ANOVA (MMRM ANOVA).</p><p><strong>Results: </strong>A total of 255 patients were screened and 102 were randomized: 50 to observation and 52 to surgery. The median age was 71 (range 65-85) years. For analysis of the primary endpoint, 41 patients in the surgery group and 40 in the observation group were available. Total hip BMD at 2 years increased by a mean of 1.3% (95% confidence interval -0.2% to 2.8%) in the surgery group and decreased by a mean of -1.4% (-2.6% to -0.2%) in the control group (P = 0.006). Analysis of total hip BMD at the end of follow-up by MMRM ANOVA showed a difference between the two groups of patients (P = 0.006). BMD of the lumbar spine increased by a mean of 4.6% (3.0% to 6.1%) in the surgery group versus 0.2% (-1.1% to 1.4%) in the observation group (P < 0.001). Analysis of lumbar spine BMD at the end of follow-up by MMRM ANOVA showed a difference between the two groups of patients (P < 0.001).</p><p><strong>Conclusion: </strong>At the 2-year follow-up, patients 65 years or older with pHPT and mild hypercalcaemia demonstrated a slight increase in BMD after parathyroidectomy.</p><p><strong>Registration number: </strong>NCT01087619 (http://www.clinicaltrials.gov).</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13627735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag154
Zhihao Li, Omid Madadi-Sanjani, Yuan Liu, Dimitri A Raptis, Vasanthakumar Gunasekaran, Ashwin Rammohan, Seisuke Sakamoto, Hajime Uchida, Piotr Kaliciński, Marek Stefanowicz, Nicolas Goldaracena, Cornelius J van Beekum, Felix J Krendl, Itsuko Chih-Yi Chen, Bryanna N Domenick, Alfred Kow, Kaihang Wang, Yuji Soejima, Katryn N Furuya, George V Mazariegos, Vidyadhar Padmakar Mali, Stephen C Dunn, Kim M Olthoff, Elizabeth B Rand, Ian Leipnitz, Chao-Long Chen, Deniz Balci, Elvan Onur Kirimker, Silvio Nadalin, Stefan Schneeberger, Debra L Sudan, Moritz Schmelzle, Uta Herden, Lutz Fischer, Blayne A Sayed, Vicky L Ng, Grzegorz Kowalewski, Mureo Kasahara, Mohamed Rela, Dieter C Broering, Qiang Xia, Pierre-Alain Clavien
{"title":"Benchmarking paediatric living donor liver transplantation for establishing standards to expand access and save lives: retrospective global cohort study.","authors":"Zhihao Li, Omid Madadi-Sanjani, Yuan Liu, Dimitri A Raptis, Vasanthakumar Gunasekaran, Ashwin Rammohan, Seisuke Sakamoto, Hajime Uchida, Piotr Kaliciński, Marek Stefanowicz, Nicolas Goldaracena, Cornelius J van Beekum, Felix J Krendl, Itsuko Chih-Yi Chen, Bryanna N Domenick, Alfred Kow, Kaihang Wang, Yuji Soejima, Katryn N Furuya, George V Mazariegos, Vidyadhar Padmakar Mali, Stephen C Dunn, Kim M Olthoff, Elizabeth B Rand, Ian Leipnitz, Chao-Long Chen, Deniz Balci, Elvan Onur Kirimker, Silvio Nadalin, Stefan Schneeberger, Debra L Sudan, Moritz Schmelzle, Uta Herden, Lutz Fischer, Blayne A Sayed, Vicky L Ng, Grzegorz Kowalewski, Mureo Kasahara, Mohamed Rela, Dieter C Broering, Qiang Xia, Pierre-Alain Clavien","doi":"10.1093/bjsopen/zrag154","DOIUrl":"10.1093/bjsopen/zrag154","url":null,"abstract":"<p><strong>Background: </strong>Paediatric liver transplantation increasingly incorporates technical variant grafts including living donor liver transplantation (LDLT) to address donor shortages. However, the technical complexity of LDLT and regional outcome variations remain challenging. In settings with such variation and ongoing debate, standardized benchmarks may guide decision-making for broader implementation. This study establishes benchmark cut-off values for paediatric LDLT outcomes to provide a validated framework for quality assessment and safe programme expansion.</p><p><strong>Methods: </strong>An international analysis was conducted of paediatric patients who underwent LDLT at 19 centres between 2019 and 2023. Benchmark cut-off values were derived from 'ideal' patients at seven high-volume institutions, representing the best achievable results under optimal conditions. Surgical complications were graded using the Clavien-Madadi classification, compared against the standard Clavien-Dindo system for accuracy.</p><p><strong>Results: </strong>In all, 2665 patients were included, of which 1988 counted as ideal patients. The median recipient age was 10 (interquartile range (i.q.r.) 6-26) months with median weight of 8.0 (i.q.r. 6.6-11.9) kg. Biliary atresia was the most common diagnosis (68.8%), and most recipients (90.9%) received a left lateral segment graft. The 75th percentile of median centre values were used to define the following benchmark cut-off values: hepatic artery thrombosis ≤ 5%, bile leak ≤ 12%, biliary anastomotic stricture ≤ 6%, and 1-year graft loss or mortality ≤ 6%. Higher centre volume was associated with more selective patient inclusion and fewer major (particularly biliary) complications. An inverse correlation between case volume and failure-to-rescue rate highlighted the critical role of multidisciplinary perioperative management. The Clavien-Madadi classification proved superior to the Clavien-Dindo system, which overclassified grade III complications.</p><p><strong>Conclusions: </strong>This study provides a framework to guide safe programme expansion, improve surgical quality, and reduce waitlist mortality.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149058331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJS OpenPub Date : 2026-09-04DOI: 10.1093/bjsopen/zrag043
Jaram Lee, Hyeung-Min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
{"title":"Effect of immunonutrition on postoperative infectious complications and survival after colon cancer surgery: long-term follow up of randomized clinical trial.","authors":"Jaram Lee, Hyeung-Min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim","doi":"10.1093/bjsopen/zrag043","DOIUrl":"10.1093/bjsopen/zrag043","url":null,"abstract":"<p><strong>Background: </strong>A previous randomized clinical trial (RCT) in patients undergoing elective colon cancer surgery showed that preoperative immunonutrition did not reduce short-term postoperative infectious complications. This study reports the long-term follow-up of that RCT, evaluating the impact of preoperative immunonutrition and the association of postoperative infectious complications with survival outcomes.</p><p><strong>Methods: </strong>This secondary analysis used prospectively collected survival data from a prior RCT in which patients were randomized 1:1 to receive either preoperative immunonutrition plus a normal diet or a normal diet alone (control) for 7 days before surgery. The primary endpoints were disease-free survival (DFS) and overall survival (OS). Survival outcomes were analysed in relation to randomized treatment allocation and clinicopathological variables, including postoperative complications, using Kaplan-Meier methods and Cox proportional hazards models.</p><p><strong>Results: </strong>A total of 161 patients were included, with 79 randomized to immunonutrition and 82 to control. The mean age was 65.3 years, and 65.8% were male, with similar baseline characteristics between groups. After a median follow-up of 57 months (range 4-65), preoperative immunonutrition did not affect 5-year DFS (80% versus 86% in controls; P = 0.474) or 5-year OS (88% versus 90%; P = 0.761). In contrast, postoperative infectious complications were associated with lower 5-year OS (74% versus 92%; P = 0.013) and showed a trend towards worse DFS (71% versus 86%; P = 0.065). On multivariable analysis, advanced T category and postoperative infectious complications remained independently associated with poorer DFS (HR 2.53; P = 0.041) and OS (HR 4.14; P = 0.007). The adverse prognostic effect of infectious complications was evident primarily in patients with advanced T category disease.</p><p><strong>Conclusion: </strong>Preoperative immunonutrition did not improve long-term survival after colon cancer surgery. Postoperative infectious complications were independently associated with worse long-term outcomes, providing prospective evidence that supports previous observational findings.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13602066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}